التفاصيل البيبلوغرافية
| العنوان: |
First assessment of covid-19 vaccine response in a population at risk. |
| المؤلفون: |
Meddis, Davide, Bordino, V., Cornio, A. R., Garlasco, J., Marengo, N., Tommaso, S. Di, Giacomuzzi, M., Memoli, G., Vicentini, C., Zotti, C. M. |
| المصدر: |
European Journal of Public Health; 2021 Supplement, Vol. 31, piii354-iii355, 2p |
| مصطلحات موضوعية: |
COVID-19, IMMUNIZATION, COVID-19 vaccines, CONFERENCES & conventions |
| مستخلص: |
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the causative agent of coronavirus disease 2019 (COVID19), has led to a global pandemic. Currently, the diagnosis of COVID-19 is confirmed by detecting SARS-CoV-2 via RealTime-RT-PCR in rhino-pharyngeal swab. Serological test is required to evaluate a previous exposure to the virus, as well as antibody response. The aim of this multicentric study is to analyse the antibody response following COVID-19 vaccination in healthcare workers and guests of nursing homes, and to determine differences between subjects with or without a confirmed previous infection. Methods: Our study included 657 subjects, recruited from guests and healthcare workers of nursing homes in the Piedmont region. 10 days after the completion of the vaccination cycle, a blood sample was taken from the subjects to measure IgG against SARS-CoV-2 spike protein. Serological testing was performed using an enzyme immunoassay kit (EUROIMMUN AntiSARS-CoV-2 QuantiVac ELISA). We performed statistical analysis with R software. Results: We recruited 657 subjects aged between 19 to 106. Among them, 404 had a previous infection and 253 didn’t have a known previous infection. The serological examination resulted positive in 655 subjects and negative in 2 (X IgG 1095 RU/ml). Samples with titer> 1200 RU/ml will be further diluted to identify the titer and differences from the baseline situation. Conclusions: This study analyses neutralizing antibodies, which should prevent the virus from binding to target cells via spike protein. According to literature, immunological response to vaccine presents a great variability of antibodies level in the study population. However, no significantly correlations were found between the available variables. Preliminary data show the presence of a very intense antibody response after active vaccine immunization both in subjects with previous infection and in the rest of the study population. Key messages: Covid-19 vaccine response in a population at risk. Differences between subjects with or without a confirmed previous infection. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Journal of Public Health is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder